(Q51573979)

7 April 2018

title

The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands. (English)

1 reference

7 April 2018

1 reference

G Griebel

1

1 reference

7 April 2018

D J Sanger

series ordinal

2

1 reference

7 April 2018

G Perrault

series ordinal

3

1 reference

7 April 2018

publication date

1 April 1996

1 reference

7 April 2018

published in

Psychopharmacology

1 reference

7 April 2018

volume

124

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

245-254

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/bf02246664

exact match

0 references

cites work

Behavioural effects of novel benzodiazepine (omega) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue

1 reference

12 December 2020

Diazepam changes risk assessment in an anxiety/defense test battery.

1 reference

12 December 2020

Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes

1 reference

12 December 2020

Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor

1 reference

12 December 2020

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

12 December 2020

Animal models for the study of anti-anxiety agents: a review

1 reference

12 December 2020

Evidence for central benzodiazepine receptor heterogeneity from behavior tests.

1 reference

12 December 2020

Novel anxiolytics that act as partial agonists at benzodiazepine receptors

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

12 December 2020

The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs

1 reference

12 December 2020

Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero.

1 reference

12 December 2020

Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice.

1 reference

12 December 2020

Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes

1 reference

12 December 2020

Type I and type II GABAA-benzodiazepine receptors produced in transfected cells

1 reference

12 December 2020

The use of a plus-maze to measure anxiety in the mouse

1 reference

12 December 2020

Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.

1 reference

12 December 2020

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

12 December 2020

Pharmacological and behavioral profile of alpidem as an anxiolytic

1 reference

12 December 2020

Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.

1 reference

12 December 2020

Anxiogenic stimuli in the elevated plus-maze.

1 reference

12 December 2020

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

12 December 2020

Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP.

1 reference

12 December 2020

Animal models of anxiety and the development of novel anxiolytic drugs

1 reference

12 December 2020

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

1 reference

12 December 2020

Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor

1 reference

12 December 2020

A model of 'antipredator' defense in Swiss-Webster mice: effects of benzodiazepine receptor ligands with different intrinsic activities

1 reference

12 December 2020

Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.

1 reference

12 December 2020

Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic

1 reference

12 December 2020

Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects

1 reference

12 December 2020

Expression and properties of recombinant alpha 1 beta 2 gamma 2 and alpha 5 beta 2 gamma 2 forms of the rat GABAA receptor

1 reference

12 December 2020

Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates

1 reference

12 December 2020

Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.

1 reference

12 December 2020

Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology.

1 reference

12 December 2020

Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.

1 reference

12 December 2020

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

12 December 2020

Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.

1 reference

12 December 2020

A synthetic non-benzodiazepine ligand for benzodiazepine receptors: A probe for investigating neuronal substrates of anxiety

1 reference

12 December 2020

Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors

1 reference

12 December 2020

Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus.

1 reference

12 December 2020

Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.

1 reference

12 December 2020

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

1 reference

12 December 2020

Differential effects of anxiolytic and non-anxiolytic benzodiazepine receptor ligands on performance of a differential reinforcement of low rate (DRL) schedule

1 reference

12 December 2020

Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.

1 reference

12 December 2020

Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors.

1 reference

12 December 2020

Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246664

1 reference

7 April 2018

1 reference

7 April 2018